Improving the reporting of non-inferiority trials by incorporating non-efficacy benefits: not all non-inferiority trials are created equal Sergio A. AcunaFahima DossaTyler R. Chesney ESSAY 19 July 2021 Pages: 1097 - 1101
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology Maarten J. G. LeeningKarim D. Mahmoud REVIEW Open access 18 November 2021 Pages: 1103 - 1109
Prioritisation and design of clinical trials Anna HeathM. G. Myriam HuninkPetros Pechlivanoglou METHODS Open access 06 June 2021 Pages: 1111 - 1121
Methodical considerations on adjusting for Charlson Comorbidity Index in epidemiological studies Sören MöllerMette BliddalKatrine Hass Rubin METHODS 04 September 2021 Pages: 1123 - 1128
Estimating the hazard rate difference from case-cohort studies Jie K. HuKwun C. G. ChanNorman E. Breslow METHODS 14 June 2021 Pages: 1129 - 1142
Meta-analysis of epigenome-wide association studies of carotid intima-media thickness Eliana Portilla-FernándezShih-Jen HwangAbbas Dehghan META-ANALYSIS Open access 06 June 2021 Pages: 1143 - 1155
Genetically predicted body composition in relation to cardiometabolic traits: a Mendelian randomization study Hailuan ZengChenhao LinXin Gao CARDIOVASCULAR DISEASE 30 June 2021 Pages: 1157 - 1168
Bone mineral density and risk of cardiovascular disease in men and women: the HUNT study Laxmi BhattaAivaras CepelisBen M. Brumpton CARDIOVASCULAR DISEASE Open access 13 September 2021 Pages: 1169 - 1177
Time trends of chronic immune diseases by year of birth in Danish registries Astrid SevelstedBo ChawesHans Bisgaard IMMUNE DISEASES 26 September 2021 Pages: 1179 - 1185
10 K: a large‐scale prospective longitudinal study in Israel Smadar ShiloNoam BarEran Segal COHORT PROFILE 15 May 2021 Pages: 1187 - 1194